REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/15/2025
Back to search
Official data from USPTO
CELLINK X
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
12/16/2025
Trademark type
Word
Nice classes
1, 5
Filing date
12/27/2017
Registration date
12/15/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/15/2020
Last transaction
12/16/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Göteborg, SE
Examiner
BUTTON,JENNIFER JO
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Cellink AB
CELLINK BIOPRINTING AB
Representatives
Margarita Wallach McCarter & English, LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biologically compatible polymershydrogels used to manufacture polymeric networks used in the manufacture of engineered living tissue for medicalscientific and non-scientific purposes; Media for cell culture for use in the biotechnological industry; Media for cell culture for use in non-medical research laboratories; Biological preparation for use in cell cultures other than for medical or veterinary use; Engineered biological tissues and tissue arrayshuman and animal organconnectiveepithelialmuscularnervous tissues and tissue arraysfor use in scientific and medical research; Biologically compatible materialshydrogels used to create polymeric networks used in the manufacture of living tissue; Proteins in raw material form for scientific and medical research
Class 5
Pharmaceutical preparations for use in the field of 3D bio-printing of tissues and organs; Preparations based on cellulous nano-fibrils for use in the 3D bio-printing of tissues and organs; Tissue-regenerative pharmaceutical preparations; Cells for medical use; Human allograft tissue; Living cells for medical use; Implants of living tissues for guided tissue regeneration; Implants comprising living tissue; Implantable materials of living tissue for use in guided tissue regeneration; Skin grafts; Surgical implants comprised of living tissues; Surgical implants of living tissues grown from stem cells; Transdermal patches for use to create skin for prosthetic limbs and for skin grafts; Living tissues for transplant; Engineered biological tissues and organshuman and animal cardiovascularpulmonarydigestivehepatobiliaryurologicalrenalendocrineconnectiveepithelialmuscularnervous tissue and organsfor medical purposes; Biological molecules to assist in the development of tissue; Haemostatic gel matrix preparations for treating wounds; Natural biomaterials for augmentation of boneblood and tissue for medical purposes; Pharmaceutical products for tissue regenerationfor tissue repairfor tissue treatmentwhether relating to human or animal tissue; Pharmaceutical preparations for the treatment of bone diseasesfor cartilaginous diseasesfor vascular diseasesfor neuronal degenerationfor degeneration of tendons and ligamentsfor retinal degenerationfor renal degenerationdegeneration of soft tissuefor diseases with abnormal cell proliferation; Natural biomaterials for bone filling; Natural biomaterials for filling cartilage; Biological tissue cultures for medical use; Biological tissue cultures for medical purposes; Biological tissue grafts; Biological bone and skin tissues impregnated with lines of oxygen for tissue engineering applications to increase cell survival in tissue intended for subsequent implantation; Gene therapy productsgenetically engineered tissues for transplant purposes; Implantable scaffolds comprising living tissue for maintaining tissue contour; Implants comprising living tissue; Natural biomaterials for augmentation of bone and tissue for medical purposes
Publications
History of USPTO decisions and trademark events.
41 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/15/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
12/15/2020
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
11/09/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/09/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
10/08/2020
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
10/08/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/27/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/27/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/27/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/27/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/27/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/14/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/19/2020
PUBO
PUBLISHED FOR OPPOSITION
05/19/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/29/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/16/2020
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
03/14/2020
GEA1
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
07/08/2019
GECD
ACTION DENYING REQ FOR RECON E-MAILED
07/08/2019
CNCF
ACTION CONTINUING FINAL - COMPLETED
07/08/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/05/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/05/2019
EXPI
EX PARTE APPEAL-INSTITUTED
05/29/2019
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
05/29/2019
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
05/29/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/28/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/28/2018
GNFR
FINAL REFUSAL E-MAILED
11/28/2018
CNFR
FINAL REFUSAL WRITTEN
11/28/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/29/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/29/2018
ALIE
ASSIGNED TO LIE
10/18/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/09/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/09/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/09/2018
GNRT
NON-FINAL ACTION E-MAILED
04/09/2018
CNRT
NON-FINAL ACTION WRITTEN
04/09/2018
DOCK
ASSIGNED TO EXAMINER
04/06/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/12/2018
NWAP
NEW APPLICATION ENTERED
12/30/2017
Continuous trademark protection
Get notified about every new filing that threatens CELLINK X or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.